Literature DB >> 8350109

Mitochondrial encephalomyopathy: variable clinical expression within a single kindred.

D Crimmins1, J G Morris, G L Walker, C M Sue, E Byrne, S Stevens, B Jean-Francis, C Yiannikas, R Pamphlett.   

Abstract

The clinical manifestations of mitochondrial encephalomyopathy are described in four generations of a single kindred. The age of onset of major neurological disturbance varied from 3-70 years. In some patients, deafness was the only manifestation; in others, recurrent bouts of status epilepticus associated with focal neurological deficits and headache, caused severe disability or death. Examples of all three adult forms of mitochondrial encephalomyopathy: MELAS, MERFF and Kearns Sayre syndrome, were represented within the kindred. Associated features included deafness, short stature, non-insulin-dependent diabetes mellitus, migraine, peptic ulceration and severe constipation. The nt 3243 A-G MELAS mutation was detected in two members of the kindred. This study highlights the diversity of clinical expression of a mitochondrial mutation within a single kindred.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350109      PMCID: PMC1015147          DOI: 10.1136/jnnp.56.8.900

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  24 in total

1.  Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases.

Authors:  T P KEARNS; G P SAYRE
Journal:  AMA Arch Ophthalmol       Date:  1958-08

2.  A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

3.  The molecular aetiology of human mitochondrial myopathies.

Authors:  V M Darley-Usmar
Journal:  Biochem Soc Trans       Date:  1987-02       Impact factor: 5.407

Review 4.  Cytochrome oxidase deficiency: clinical and biochemical heterogeneity.

Authors:  S DiMauro; M Zeviani; S Servidei; E Bonilla; A F Miranda; A Prelle; E A Schon
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

5.  Mitochondrial DNA. Small, beautiful and essential.

Authors:  L A Grivell
Journal:  Nature       Date:  1989-10-19       Impact factor: 49.962

6.  Familial spongy degeneration of the central nervous system (Van Bogaert-Bertrand disease). An ultrastructural study.

Authors:  P Gambetti; W J Mellman; N K Gonatas
Journal:  Acta Neuropathol       Date:  1969-01-31       Impact factor: 17.088

7.  A new disease-related mutation for mitochondrial encephalopathy lactic acidosis and strokelike episodes (MELAS) syndrome affects the ND4 subunit of the respiratory complex I.

Authors:  P Lertrit; A S Noer; M J Jean-Francois; R Kapsa; X Dennett; D Thyagarajan; K Lethlean; E Byrne; S Marzuki
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

8.  A tRNA(Lys) mutation in the mtDNA is the causal genetic lesion underlying myoclonic epilepsy and ragged-red fiber (MERRF) syndrome.

Authors:  A S Noer; H Sudoyo; P Lertrit; D Thyagarajan; P Utthanaphol; R Kapsa; E Byrne; S Marzuki
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

9.  Significance of basal ganglia calcification on computed tomography in children.

Authors:  A Legido; R A Zimmerman; R J Packer; L T Bilaniuk; K R Siegel; G D'Angio
Journal:  Pediatr Neurosci       Date:  1988

10.  Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities ): disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature.

Authors:  N Fukuhara; S Tokiguchi; K Shirakawa; T Tsubaki
Journal:  J Neurol Sci       Date:  1980-07       Impact factor: 3.181

View more
  10 in total

1.  Tissue specific distribution of the 3243A->G mtDNA mutation.

Authors:  A L Frederiksen; P H Andersen; K O Kyvik; T D Jeppesen; J Vissing; M Schwartz
Journal:  J Med Genet       Date:  2006-02-20       Impact factor: 6.318

2.  Multiple presentation of mitochondrial disorders.

Authors:  A Nissenkorn; A Zeharia; D Lev; A Fatal-Valevski; V Barash; A Gutman; S Harel; T Lerman-Sagie
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

3.  Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.

Authors:  Beatrice Alexandra Golomb; Hayley Jean Koslik; Alan J Redd
Journal:  BMJ Case Rep       Date:  2015-10-05

4.  Response to Letter to the Editor: Can MR spectroscopy and muscle biopsy findings be correlated in MELAS and CPEO?

Authors:  Feng-Nan Niu; Hai-Lan Meng; Ren-Yuan Liu; Bing Zhang; Yun Xu
Journal:  CNS Neurosci Ther       Date:  2017-10       Impact factor: 5.243

5.  Neuroradiological features of six kindreds with MELAS tRNA(Leu) A2343G point mutation: implications for pathogenesis.

Authors:  C M Sue; D S Crimmins; Y S Soo; R Pamphlett; C M Presgrave; N Kotsimbos; M J Jean-Francois; E Byrne; J G Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

Review 6.  Diagnosis of inherited metabolic disorders affecting the nervous system.

Authors:  P D Swanson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

Review 7.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

8.  Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations.

Authors:  Carolyn M Sue; Shanti Balasubramaniam; Drago Bratkovic; Catherine Bonifant; John Christodoulou; David Coman; Karen Crawley; Fabienne Edema-Hildebrand; Carolyn Ellaway; Roula Ghaoui; Maina Kava; Lisa S Kearns; Joy Lee; Christina Liang; David A Mackey; Sean Murray; Merrilee Needham; Rocio Rius; Jacqui Russell; Nicholas J C Smith; Dominic Thyagarajan; Christine Wools
Journal:  Intern Med J       Date:  2021-11-19       Impact factor: 2.611

Review 9.  Gastrointestinal manifestations of mitochondrial disorders: a systematic review.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Therap Adv Gastroenterol       Date:  2016-10-06       Impact factor: 4.409

10.  Diagnosis of adult-onset MELAS syndrome in a 63-year-old patient with suspected recurrent strokes - a case report.

Authors:  Tim Sinnecker; Michaela Andelova; Michael Mayr; Stephan Rüegg; Michael Sinnreich; Juergen Hench; Stephan Frank; André Schaller; Christoph Stippich; Jens Wuerfel; Leo H Bonati
Journal:  BMC Neurol       Date:  2019-05-08       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.